1,095
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Heparin removal from human plasma using molecular imprinted cryogels

&
Pages 403-412 | Received 06 Feb 2014, Accepted 19 Feb 2014, Published online: 01 Apr 2014

References

  • Alkan H, Bereli H, Baysal Z, Denizli A. 2009. Antibody purification with protein A attached supermacroporous poly(hydroxyethyl methacrylate) cryogel. Biochem Eng J. 45:201–208.
  • Alkan H, Bereli H, Baysal Z, Denizli A. 2010. Selective Removal of the autoantibodies from rhematoid artritis patient plasma using protein A carrying affinity cryogels.Biochem Eng J. 51:153–159.
  • Arrua RD, Alvarez Igarzabal CI. 2011. Macroporous monolithic supports for affinity chromatography. J Sep Sci. 34:16–17.
  • Baydemir G, Andaç M, Bereli N, Say R, Denizli A. 2007. Selective removal of Bilirubin with bilirubin-imprinted particles.Ind Eng Chem Res. 46:2843‐2852.
  • Bereli N, Saylan Y, Uzun L, Say R, Denizli A. 2011. L-Histidine imprinted supermacroporous cryogels for cytochrome C recognition.Sep Purif Technol. 82:28–35.
  • Cheong WJ, Yang SH, Ali F. 2013. Molecular imprinted polymers for separation science: a review of reviews. J Sep Sci. 36:609–628.
  • Chong BH. 2003. Heparin-induced thrombocytopenia.J Thromb Haemost1:1471–1478.
  • Cormack P, Mehamod FS. 2013. Molecularly imprinted polymer synthesis using raft polymerisation.Sains Malays. 42:529–535.
  • Demiryas N, Tüzmen N, Galaev IY, Pişkin E, Denizli A. 2007. Poly(acrylamide-allyl glycidyl ether) cryogel as a novel stationary phase in dye-affinity chromatography. J Appl Polym Sci. 105: 1808–1816.
  • Denizli A. 1999. Heparin-Immobilized Poly(2-Hydroxyethylmethacrylate based microspheres. J Appl Polym Sci. 74:655–662.
  • Denizli A. 2002. Preparation of immune-affinity membranes for cholesterol removal from human plasma. J Chrom B. 772:357–367.
  • Denizli A, Pişkin E. 1995. Heparin-immobilized polyhydroxyethylmethacrylate microbeads for cholesterol removal: a preliminary report. J Chromat B. 670:157–161.
  • Derazshamshir A, Baydemir G, Andaç M, Say R, Galaev IY, Denizli A. 2010. Molecularly imprinted PHEMA based cryogels for depletion of hemoglobin. Macromol Chem Phys. 221:657–668.
  • Engelberg H. 1984. Heparin and the atherosclerotic process. Pharmacol Rev. 36:91–110.
  • Ergün B, Baydemir G, Andaç M, Yavuz H, Denizli A. 2012. Ion imprinted cryogels for in vitro removal of iron from beta-thalassemic human plasma. J Appl Polym Sci. 125:254–262.
  • Finette GM, Mao QM, Hearn MT. 1997. Comparative studies on the isothermal characteristics of proteins adsorbed under batch equilibrium conditions to ion-exchange, immobilised metal ion affinity and dye affinity matrices with different ionic strength and temperature conditions. J Chromatogr A. 763:71–90.
  • Gaus K, Hall EAH. 1998. Surface Plasmon Resonance sensor for heparin measurements in blood plasma. Biosens Bioelectron. 13: 1307–1315.
  • Haginaka J, Sanbe H, Takehira H. 1999. Uniform-sized molecularly imprinted polymer for (s)-ibuprofen retention properties in aqueous mobile phase. J Chromatogr A. 857:117–125.
  • Haginaka J. 2008. Monodispersed, molecularly imprinted polymers as affinity-based chromatography media. J Chromatogr B. 866:3–13.
  • He Q, Zhang J, Chen F, Guo L, Zhu Z, Shi J. 2010. An anti- ROS/hepatic brosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticlesBiomaterials. 31:7785–7796.
  • Jacques LB. 1973. Protamine: Antagonist to heparin. Can Med Assoc J. 108:1291–1297.
  • Jang IK, Hursting MJ. 2005. When heparins promote thrombosis; review of heparin-induced thrombocytopenia. Circulation. 111:2671–2683.
  • Kaminsky K, Zazakowny K, Szczubialka K, Nowakowska M. 2008. pH sensitive genipin-cross-linked chitosan microspheres for heparin removal. Biomacromolecules9:3127–3132.
  • Koç I, Baydemir G, Bayram E, Yavuz H, Denizli A. 2011. Selective removal of 17β- estradiol with molecularly imprinted particle embedded cryogel system. J Hazard Mater. 192:1819–1826.
  • Komiyama M, Takeuchi T, Mukawa T, Asanuma H. 2003. Molecular Imprinting: From Fundamentals to Applications. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA.
  • La Spina R, Tripisciano C, Mecca T, Cunsolo F, Weber V, Matiasson B. 2014. Chemically modified poly(2-hydroxyethyl methacrylate) cryogel for the adsorption of heparin. J Biomed Mater Res Part B doi:10.2012/jbm.b.33104.
  • Labrou NE, Clonis YD. 1995. The interaction of Candida boidinii formate dehydrogenase with a new family of chimeric biomimetic dye-ligands.Arch Biochem Biophys. 316:169–178.
  • Langer R, Linhardt RJ, Hoffberg S, Larsen AK, Cooney CL, Tapper D, Klein M. 1982. An enzymatic system for removing of heparin in extracorporeal theraphy. Science217:261–263.
  • Laura P, Prandi C, Coppa M, Sparnacci K, Laus M, Lagana A, et al. 2002. Uniformly sized molecularly imprinted polymers (MIPs) for 17β- estradiol. Macromol Chem Phys. 203:1532–1538.
  • Li L, Liang Y, Liu Y. 2013. Designing of molecularly imprinted polymer-based potentiometric sensor for the determination of heparin. Anal Biochem. 434:242–246.
  • Li W, Li S. 2007. Molecular imprinting: a versatile tool for separation, sensors and catalysis. Adv Polym Sci. 206:191–210.
  • Lozinsky VI, Plieva FM, Galaev IY., Mattiasson B. 2001. The potential of polymeric cryogels in bioseparation. Bioseparation10:163–188.
  • Lozinsky VI, Galaev IY, Plieva FM, Savina IN, Jungvid H, Mattiasson B. 2003. Polymeric cryogels as promising materials of biotechnological interest. Trends Biotechnol. 21:445–451.
  • Ma X, Mohammad SF, Kim SW. 1992. Heparin removal from blood using poly(L-Lysine) immobilized hollow fiber. Biotechnol Bioeng40:530–536.
  • Noti C, Seeberger PH. 2005.Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans.Chem Biol12:731–756.
  • Piletsky SA, Turner NW, Laitenberger P. 2006. Molecularly imprinted polymers in clinical diagnostics-Future potential and existing problems. Med Eng Phys. 28:971–977.
  • Umpleby RJ, Baxter SC, Chen Y, Shah RN, Shimizu KD. 2001. Characterization of MIPs using heterogeneous binding models.Anal Chem. 73:4584–4591.
  • Warkentin TE, Greinacher A. 2004. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest J. 126:311–337.
  • Warkentin TE. 2003. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 121:535–555.
  • Warkentin TE. 2004. Heparin-induced thrombocytopenia. Diagnosis and management. Circulation110:454–458.
  • Wulff G. 1995. Molecular imprinting in cross-linked materials with the aid of molecular templates - A way towards artificial antibodies. Angew Chem 34:1812–1832.
  • Wulff G. 2002. Enzyme-like catalysis by molecularly imprinted polymers. Chem Rev. 102:1–27.
  • Yıldırım A, Özgür E, Bayındır M. 2013. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-spesific protein adsorption. J Mater Chem. 1:1909–1920.
  • Yoshimi Y, Sato K, Ohshima M, Pletska E. 2013. Application of the ‘gate effect’ of a molecularly imprinted polymer grafted on an electrode for the real-time sensing of heparin in blood. Analyst. 138:5121–5128.
  • Zhu AP, Ming Z, Jian S. 2005. Blood compatibility of chitosan/ heparin complex surface modified ePTFE vascular graft. Appl Surf Sci. 241:485–492.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.